Literature DB >> 20591488

Predictors of mortality within 90 days of cataract surgery.

Paul B Greenberg1, Jeffrey Liu, Wen-Chih Wu, Lan Jiang, Victoria L Tseng, Ingrid U Scott, Peter D Friedmann.   

Abstract

PURPOSE: To identify predictors of mortality within 90 days of cataract surgery.
DESIGN: A retrospective cohort study. PARTICIPANTS: A total of 45,082 patients who underwent cataract surgery in the Veterans Health Administration (VHA) between October 1, 2005 and September 30, 2007.
METHODS: The National Patient (US) Care Database (NPCD) was used to identify all patients who underwent outpatient extracapsular cataract surgery performed in the VHA and who had only 1 cataract surgery within 90 days of the index surgery. Data collected includes demographics, number of hospitalizations within 1 year before surgery, postoperative mortality, and systemic comorbidities using the Charlson Comorbidity Index (CCI), which predicts the 1-year mortality for a patient based on a range of co-morbid conditions scored 1, 2, 3 or 6 depending on the risk of dying associated with the condition. Adjusted odds ratios (OR) of factors predictive of 90-day mortality were calculated using logistical regression modeling. MAIN OUTCOME MEASURES: Mortality within 90 days of cataract surgery.
RESULTS: Of the 53,786 patients who underwent cataract surgery during the study period, 45,082 met inclusion criteria. Mean age was 71.8 years; 97.6% were men; 5.0% had complex cataract surgery. The most frequent systemic comorbidities in the CCI were diabetes mellitus (40.6%), chronic pulmonary disease (21.2%), malignant neoplasms (12.5%) and congestive heart failure (CHF; 9.5%). Patients had a median CCI score of 1; 43.7% had a score ≥ 2. Mortality rate within 90 days after cataract surgery was 7.1 per 1000 patients. Independent predictors of 90-day postoperative mortality were [adjusted OR, (95% confidence interval; CI)]: age 80 or greater [2.54 (1.62, 3.98)], CCI ≥ 2 [2.06 (1.58, 2.70)], ≥ 1 hospitalizations in the past year [1.85 (1.45, 2.36)], chronic pulmonary disease (CPD) [1.69 (1.34, 2.14)], CHF [1.71 (1.29, 2.14)], cirrhosis [2.60 (1.31, 5.15)], multiple myeloma or leukemia [2.20 (1.07, 4.53)], and metastatic solid tumor [4.17 (1.80, 9.66)].
CONCLUSIONS: The risk of 90-day mortality after cataract surgery is low, even for patients at higher risk for mortality such as the elderly and those with a high preoperative disease burden.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20591488     DOI: 10.1016/j.ophtha.2010.02.009

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Limited Utility of Routine Tests Prior to Ophthalmologic Surgery: An Observational Study in a Japanese Hospital.

Authors:  Mitsuhiro Matsuo; Yoshinori Takemura; Mitsuaki Yamazaki
Journal:  JMA J       Date:  2021-07-06

2.  Rejuvenation effects of cataract surgery with ultraviolet blocking intra-ocular lens on circadian rhythm and gait speed.

Authors:  Masahiko Ayaki; Kazuno Negishi; Kazuo Tsubota
Journal:  Rejuvenation Res       Date:  2014-08       Impact factor: 4.663

3.  Hospitalization after Cataract Surgery in a Nationwide Managed-Care Population.

Authors:  Sophia Y Wang; Taylor S Blachley; Chris A Andrews; John Z Ayanian; Paul P Lee; Joshua D Stein
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

4.  The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.

Authors:  Annie M Wu; Connie M Wu; Paul B Greenberg; Fei Yu; Flora Lum; Anne L Coleman
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.